Copper's Rally Is Back. This $31M Junior Is Sitting on a Potential Fortune

A high-grade copper-gold discovery in Quebec just delivered extremely high grade intercepts. Valuation? Just $31M. With copper breaking out, the timing here could be perfect. Get the symbol here.

IONS
Ionis Pharmaceuticals Inc
NASDAQ
42.15
Open 41.55 Prev Close 41.34
High 42.55 Low 41.44
Volume 331,641 Volume (Avg) 1,735
52 Week High 52.34 52 Week Low 23.95
Market Cap 6.7B PE Ratio

Shares Stats

Shares Outstanding159,040,000
Shares Float155,280,000
Shares Short14,230,000
Insider Holdings81%
Institution Holdings108.13%

About Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels in adults with familial chylomicronemia syndrome (FCS) and acute pancreatitis; WAINUA for the treatment of the polyneuropathy of hereditary transthyretin-medicated amyloidosis (ATTRv-PN) in adults; and SPINRAZA for pediatric and adult patients with spinal muscular atrophy (SMA). It also provides QALSODY for the treatment of Amyotrophic Lateral Sclerosis (ALS); TEGSEDI for the treatment of ATTRv-PN in adults; and WAYLIVRA for treatment for FCS and familial partial lipodystrophy. It also develops products under Phase 3 clinical trials, such as Olezarsen for patients with hypertriglyceridemia (SHTG) and cardiovascular disease (CVD); Donidalorsen for patients with hereditary angioedema; and Zilganerse, a potential treatment for people with genetically confirmed Alexander disease, as well as ION582 that has completed Phase 2 clinical trial for the potential treatment of AS, a rare genetic neurological disease. In addition, the company develops Eplontersen to degrade mutant and wild-type TTR mRNA through binding to the TTR mRNA; Pelacarsen to inhibit the production of apolipoprotein(a) in the liver to offer a direct approach for reducing lipoprotein(a); Bepirovirsen to inhibit the production of viral proteins associated with hepatitis B virus; Sefaxersen to reduce the production of complement factor B and lower activation of the alternative complement pathway; and Ulefnersen to reduce the production of the fused in sarcoma, as well as other mid-stage pipeline investigational medicines. It has a strategic collaboration with Biogen for the treatment of neurological disorders; and collaboration and license agreement with GSK, AstraZeneca, Novartis, and Roche, as well as with Metagenomi. The company was incorporated in 1989 and is headquartered in Carlsbad, California.

General

NameIonis Pharmaceuticals Inc
TickerIONS
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees1,069

Highlights

Analyst Target56.62
Market Cap6,708,600,000
PEG Ratio25.70
EBITDA-460,854,016

Financials

Curr Year EPS Estimate-2.29
Next Quarter EPS Estimate-0.87
Profit Margin-63.77%
Operating Margin-65.71
Return on Assets-0.11
Return on Equity-1.19
Revenue717.7M
Earnings Per Share-2.99
Revenue Per Share4.69
Gross Profit-181,148,000
Quarterly Revenue Growth0.10

Valuation

Forward PE90.91
Price/Sales (Trailing 12 Mt.)9.17
Price/Book (Most Recent Quarter)13.83

Earnings

Most Popular

SoundHound AI Plunged 35% In 2025 - Is It Still Worth Owning?

SoundHound AI stock soared but plunged 35% YTD due to Nvidia exiting its stake, Jim Cramer's sell recommendation, and mixed Q1 results. Potential rivals, including Meta Platforms and OpenAI, pose competition. Analysts have a consensus price forecast of $10.50 for SoundHound AI.

UK royals welcome Macron for state visit with migration and Ukraine high on the agenda

LONDON (AP) — French President arrived in Britain on Tuesday for a mixing with thorny political talks about stopping migrants from .

This Rare Metal Spiked 300%-And One Tiny Firm May Be Riding the Surge - Ad

Antimony prices soared last year, but few investors noticed. One firm, sitting on a historic deposit, is perfectly positioned to benefit as demand grows for defense.

Trump's 'Big, Beautiful Bill' Offers Seniors A $6,000 'Bonus' Tax Deduction: Here's How You Qualify For The Benefit

Trump's Big, Beautiful Bill offers a $6,000 senior bonus deduction from 2025-28. Couples can save $12,000. Retirees with incomes up to $75,000 benefit most.

Gold Just Hit Another Record. This Junior Could Be Next. - Ad

This copper junior was the smallest company invited to a top global mining conference. With nearly 1B pounds CuEq and 50,000m of funded drilling, this story won't stay quiet for long.

Shares in Asia are mixed amid Trump's new tariff deadlines

Shares were mixed in Asia on Wednesday, following a choppy trading day on Wall Street as the Trump administration pressed its campaign to win more favorable trade deals with nations around the globe.

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after July 23rd, it may be too late.

Social Security Administration Sends 'Unbelievable' Email On Trump's 'Big, Beautiful Bill': Report

Email from SSA claims Trump's tax law will eliminate taxes on Social Security benefit. Critics call it politically motivated and incorrect.

Jasper Therapeutics Shares Fall On Briquilimab Drug Lot Problem

Jasper shares drop after updated BEACON study shows strong results but faces disruption from compromised drug product lot and halted pipeline programs.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.

China imposes export ban on companies tied to Taiwan’s military

TAIPEI, Taiwan (AP) — China imposed export controls Wednesday on eight companies tied to Taiwan’s military as the self-ruled island started annual military exercises.

Meet the Investor Who Hopes Markets Get Worse - Ad

Market downturns are painful for most. But not for Jeff Clark... His Crossfire strategy thrives when markets spiral out of control, delivering gains like 388%, 1,263%, and 1,285%... sometimes in as little as two days. If you want to be prepared to profit from the next market downturn, watch his new video walkthrough. He explains the whole thing from beginning to end, and it won't cost you a penny.

Netflix Quietly Circles Shark Week With A Killer Strategy

Not even "Shark Week" is safe from Netflix. Here's how the streaming giant is pushing against cable dominance for summer shark content.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

Trump Says Jerome Powell Should 'Resign Immediately' After FHFA Director Alleges Fed Chair Lied About $2.5 Billion Renovation Plan

In Big Tech Just Before Congressional Hearing: ReportTrump wants Powell gone over testimony liesTrump demands Powell's resignation after accusations of misleading testimony from Federal Housing Finance Agency Director. Trump has been critical of Powell in the past.

China retaliates against EU with a ban on European medical devices

BANGKOK (AP) — China said Sunday that European medical device companies will be barred from selling to the Chinese government as a countermeasure for the European Union's restrictions on the sale of similar products from China.

Copper's Spiking - And This Junior Has the Grades to Match - Ad

Copper is climbing again - and this time, it looks tariff-proof. A $31M junior just posted nearly 1B lbs of copper equivalent. With insiders and institutions piling in, this could be the next breakout.

A judge resisted Trump’s order on gender identity. The EEOC just fired her

The federal agency charged with protecting workers’ civil rights has terminated a New York administrative judge who , including President Donald Trump’s executive order decreeing male and female as .

How to Hack a $1.3T Market - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

Sam Altman's Endorsement Skyrockets Crib Sales, Cradlewise CEO Reveals

Sam Altman, the CEO of OpenAI, has been credited with a significant sales boost for crib manufacturer Cradlewise, following his endorsement of the product.

Cathie Wood's Alpha Surge: $250 Million Circle Windfall, Big AMD Buys

Cathie Wood, founder and CEO of ARK Invest, has recently been on a hot streak of successful and high-profile trades through her flagship ARK ETFs. 

AI Has a Dirty Secret... - Ad

AI firms are using your data-now a forgotten U.S. law unlocks a way to get paid. With just $10 and 5 minutes, you could start collecting up to $3,452.50/month in "AI Equity Checks." This could be the easiest passive income stream yet.

Meta, KKR, Lululemon And An Industrial Stock On CNBC's 'Final Trades'

Experts predict KKR, Lululemon, Meta Platforms, and Rockwell Automation to perform well.

Copper's Rally Is Back. This $31M Junior Is Sitting on a Potential Fortune - Ad

A high-grade copper-gold discovery in Quebec just delivered extremely high grade intercepts. Valuation? Just $31M. With copper breaking out, the timing here could be perfect. Get the symbol here.

FDA requires updated warning about rare heart risk with COVID shots

WASHINGTON (AP) — said Wednesday it has expanded existing warnings on the two leading COVID-19 vaccines about a rare heart side effect mainly seen in young men.

Bernie Sanders Shares First Thing He Would Do As President — And It Could Be A Jab At Elon Musk

Bernie Sanders lost the 2016 and 2020 presidential races. In a recent interview, Sanders shared what he would do first if he were president.

This Rare Metal Spiked 300%-And One Tiny Firm May Be Riding the Surge - Ad

Antimony prices soared last year, but few investors noticed. One firm, sitting on a historic deposit, is perfectly positioned to benefit as demand grows for defense.

Shaquille O'Neal Wants $50 Million From Lakers Following $10 Billion Sale

Citing his past contributions to the Laker's success, Shaquille O'Neal jokingly requested a $50 million payout after a $10 billion sale.

Gen Z Loves Job-Hopping, But This Boss Who Stayed In The Same Company For 35 Says There's An Upside To Staying Put

CEO Janet Godwin says best advice was to focus on current job, not next promotion. Gen Z prioritizes flexibility, while job hopping can lead to higher earnings but also impact retirement savings.

Gold Just Hit Another Record. This Junior Could Be Next. - Ad

This copper junior was the smallest company invited to a top global mining conference. With nearly 1B pounds CuEq and 50,000m of funded drilling, this story won't stay quiet for long.

Cash-Rich IonQ To Capture 20% Of Quantum Market By 2035

IonQ shares climb as investors rally behind its bold quantum growth strategy and long-term market potential.

Trump vents online about service provider after conference call marred by glitch

WASHINGTON (AP) — On Monday afternoon, the president of the United States was just another person complaining online about his service provider.

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after July 23rd, it may be too late.

Medical Groups Sue RFK Jr. For Assault On Science Over Unlawful COVID-19 Vaccine Rollbacks

Major health groups sue HHS and Robert F. Kennedy Jr. over COVID-19 vaccine policy changes for children and pregnant individuals.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service